PERIOD ENDING | 28-Mar-04 | 31-Dec-03 | 28-Sep-03 | 29-Jun-03 | Total Revenue | 12,487,000 | 14,166,000 | 12,504,000 | 9,993,000 | Cost of Revenue | 1,794,000 | 3,373,000 | 3,366,000 | 2,028,000 | | Gross Profit | 10,693,000 | 10,793,000 | 9,138,000 | 7,965,000 | | | Operating Expenses | | Research Development | 1,649,000 | 2,318,000 | 1,878,000 | 1,717,000 | | Selling General and Administrative | 3,933,000 | 4,682,000 | 4,042,000 | 3,774,000 | | Non Recurring | 1,202,000 | 387,000 | 216,000 | 5,416,000 | | Others |
-
|
-
| (647,000) | 647,000 | | | | Total Operating Expenses |
-
|
-
| 5,489,000 | 11,554,000 | | | Operating Income or Loss | 3,909,000 | 3,406,000 | 3,649,000 | (3,589,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (780,000) | (2,455,000) | (1,155,000) | 132,000 | | Earnings Before Interest And Taxes | 3,129,000 | 951,000 | 2,494,000 | (3,457,000) | | Interest Expense |
-
|
-
|
-
| (51,000) | | Income Before Tax | 3,129,000 | 951,000 | 2,494,000 | (3,406,000) | | Income Tax Expense | 809,000 | 335,000 | 251,000 | 271,000 | | Minority Interest | (2,000) | (2,000) | (3,000) | 2,000 | | | | Net Income From Continuing Ops | 2,318,000 | 614,000 | 2,240,000 | (3,675,000) | | | Non-recurring Events | | Discontinued Operations | 13,000 | (12,000) | (5,000) | 83,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | Net Income | 2,331,000 | 602,000 | 2,235,000 | (3,592,000) | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | Net Income Applicable To Common Shares | $2,331,000 | $602,000 | $2,235,000 | ($3,592,000) |
|